Navigation Links
Ohio Sales Rep's Information Launched Massive Government Investigation of Cephalon
Date:9/29/2008

Unique off-label marketing case results in $425M settlement

WASHINGTON, Sept. 29 /PRNewswire/ -- The government's investigation into Cephalon Inc.'s illegal marketing practices that culminated in today's $425,000,000 settlement and guilty plea by the pharmaceutical company began in January 2003 with a Cephalon sales representative in Ohio.

The sales representative, Bruce Boise, refused to follow company-ordered sales strategies to convince doctors to prescribe Cephalon's Actiq, Gabitril and Provigil drugs for unapproved ("off-label') uses because he was worried the sales practices were illegal and the "off-label" uses were dangerous for patients.

Boise was so concerned about Cephalon's off-label marketing that he contacted the Food and Drug Administration (FDA) to inform them of what the company was doing and then agreed to wear a wire to a company sales conference to help the government gather evidence.

The decision to report Cephalon to the FDA cost Boise his job and future employment in the pharmaceutical industry. But his information helped end Cephalon's illegal marketing practices that put patients at risk and led to today's settlement.

Cephalon Inc. (Nasdaq: CEPH), a pharmaceutical company based in Frazer, Pennsylvania, will pay the federal government and numerous states a total of $375 million to settle four "qui tam" (whistleblower) lawsuits alleging Medicare and Medicaid fraud involving the sales and marketing of Actiq, Gabitril and Provigil between 2001 and 2006. At the same time, Cephalon has agreed to plead guilty to a criminal charge involving off-label marketing of the drugs and will pay a $50 million fine.

"What makes this case unique is that it's the first time, in the absence
'/>"/>

SOURCE Phillips & Cohen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alert Alarm Michigan Seeks Employees With Inside and Outside Sales Experience
2. Ellex Commences Direct Sales in Germany
3. Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8%
4. Healthcare Executive Richard Peitzmeier Returns to Phoenix as Regional Sales Director of SCAN Health Plan Arizona
5. Driving Toward Cleaner Air: July Gasoline Sales in Minnesota Decline By 9%, E85 Sales Up 16%
6. State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales
7. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
8. Sales of Emerging Novel Pain Therapies Will Represent More than One-Fifth of the Total Pain Drug Market by 2023
9. Despite Bad Economy Botox Sales Are Booming
10. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
11. P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Today, Yunx.co.uk, a hot style dress ... other special occasion outfits, unveils 65 new bridesmaid ... at discounted prices, up to 80% off. , Yunx.co.uk’s ... their fashionable designs, gorgeous looks and delicate craftsmanship. These ... is devoted to designing and offering high-quality women’s dresses ...
(Date:12/24/2014)... a famous bamboo flooring company offering bamboo flooring products ... its multiple layer bamboo panel board collection , and ... Bamboo panel is the product made from 100 percent ... features high quality selective bamboo and eco-friendly adhesives that ... consists of multiple layers of bamboo. , According to ...
(Date:12/24/2014)... Hepatitis C infection does not contribute to mental decline in ... advances have made it possible for people with HIV to ... mood swings and other types of mental impairment as they ... infections with other viruses -- a common problem in people ... prime suspects has been the hepatitis C virus, which infects ...
(Date:12/24/2014)... News) -- Researchers say they have used human embryonic ... and sperm. While this had already been done ... that these types of cells -- called primordial germ ... cells, according to the team at the University of ... cells is one of the earliest events during early ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 ... (ADA) call for giving the cholesterol-lowering drugs known as statins ... These new standards bring the association in line with ... also recommend giving low- or high-dose statins to all people ... "We agree that the decision to start a statin should ...
Breaking Medicine News(10 mins):Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3
... according to a new study. This is a significant finding ... increased and remained unchanged among black women during the last ... Sept. 24, issue of JAMA ( Journal of ... by David A. Lieberman, M.D., head of gastroenterology, Oregon Health ...
... ALEXANDRIA, Va., Sept. 24 The nation,s,leading association ... the importance of respecting the end of life ... President and CEO of the Assisted Living Federation,of ... seniors,know what is best for them in testimony ...
... by union and nonunion caregivers blends online,phone-bank technology ... WASHINGTON, Sept. 24 With women voters,poised to ... a unique,project of SEIU Healthcare will reach at ... workforce -- through worker-to-worker,communication on the candidates, views ...
... markers were analyzed in 83 cases of colorectal ... chain reaction (PCR). PCR products were eletrophoresed on ... Genotype 3.7 software were used for loss of ... features, significant relationship was observed between LOH frequencies ...
... 24 Americans United for Life,(AUL) has filed ... Services,(HHS) affirming the need for a proposed regulation ... providers nationwide., Dr. Charmaine Yoest, President and ... providers is critical to the continuing viability and,safety ...
... Sept. 24 PartsSource, the nation,s,leading supplier of replacement ... fastest growing company on the 2008 INC 500,for healthcare. ... recognized by INC magazine as one of the fastest ... have a publication as esteemed as INC,magazine recognize our ...
Cached Medicine News:Health News:Black Americans are at higher risk for colon polyps 2Health News:ALFA Honors End of Life Choices 2Health News:Nurses, Healthcare Workers Launch Massive Drive to Inform 1 Million Caregivers in Key States on Obama and McCain Healthcare Plans 2Health News:LOH analysis on 4q in sporadic colorectal carcinoma 2Health News:Conscience Protections Essential to Healthcare System, Americans United for Life Argues in Comments Filed with HHS 2
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ) ... Analysis of the US Medical Device Sector " ... http://photos.prnewswire.com/prnh/20130307/600769 This analysis ... identifies the key trends and rationale for undertaking ... and acquisitions. The study will be ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a global leader ... today announced it will participate in the 33 rd ... in San Francisco . ... speak at 11:00 AM Pacific Time.  A live audio webcast ... Investor Relations link on the Cyberonics home page at ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today issued the following open letter to ... , Dr. Med. Sc. Dear RXi ... a number of inaccurate statements posted on certain ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... million people are diagnosed with varicose veins ... patients never seek treament and are apprehensive ... offer them an effective alternative to conventional ... or hook phlebectomy), is considered a laborious ...
...
Inquire...
... in a Compact Size , Featuring design ... along with Alokas latest proprietary electronic technologies, ... portable units suffer from hardware and software ... sets new standards for whats possible in ...
Medicine Products: